Cerebral Microemboli in Venoarterial ECMO Patients

NCT ID: NCT02020759

Last Updated: 2019-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Extracorporeal membrane oxygenation (ECMO) is progressively used in critically ill patients with cardiac or respiratory failure as a bridging option for potential organ recovery. However, ECMO survivors often suffer from poor neurocognitive outcome due to neurological complications such as microembolic (ME) strokes.

In venoarterial (va) ECMO circuits the pulmonary circulation, which usually serves as microembolic filter, may be bypassed and generated ME are prone to reach the brain in substantial amounts and potentially impair cerebral integrity. Although patient exposure to cerebral ME has been thoroughly investigated in cardiopulmonary bypass procedures, there is only limited research on cerebral ME in patients undergoing ECMO therapy.

The primary study goal of this study is to determine the load and nature of cerebral ME in critically ill patients under va-ECMO support. We also aim to compare the results to measurements in healthy subjects und intensive care unit (ICU) patients without extracorporeal support to get a better impression on the relevance of ME generation during ECMO support.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The addition of ICU patients was made according to reviewer suggestions after an initial submission to a medical journal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complication of Extracorporeal Membrane Oxygenation Cerebral Microembolism Cerebral Perfusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient on ECMO

Neurological monitoring with transcranial Doppler ultrasound

Transcranial Doppler Ultrasound

Intervention Type DEVICE

Transcranial Doppler Ultrasound is used to monitor cerebral microembolism

Healthy subjects

Neurological monitoring with transcranial Doppler ultrasound

Transcranial Doppler Ultrasound

Intervention Type DEVICE

Transcranial Doppler Ultrasound is used to monitor cerebral microembolism

ICU patients

Neurological monitoring with transcranial Doppler ultrasound

Transcranial Doppler Ultrasound

Intervention Type DEVICE

Transcranial Doppler Ultrasound is used to monitor cerebral microembolism

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial Doppler Ultrasound

Transcranial Doppler Ultrasound is used to monitor cerebral microembolism

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intensive care patients with cardiac or respiratory failure under va-ECMO therapy
* Age \> 18 yrs.
* Signed informed consent

Exclusion Criteria

* use of any other extracorporeal device including venovenous (vv) ECMO
* continuous renal replacement therapy
* medical history of severe mitral or aortic stenosis
* medical history of severe mitral or aortic regurgitation
* medical history of carotid stenosis \> 70 %
* septicaemia
* medical history of vascular dementia or Alzheimer's disease
* inclusion in an other clinical study
* gravidity
* allergy against materials of one of the medical device used in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Gabor Erdoes

Dr Gabor Erdoes

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gabor Erdoes, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Kietaibl C, Horvat Menih I, Engel A, Ullrich R, Klein KU, Erdoes G. Cerebral microemboli during extracorporeal life support: a single-centre cohort study. Eur J Cardiothorac Surg. 2021 Dec 27;61(1):172-179. doi: 10.1093/ejcts/ezab353.

Reference Type DERIVED
PMID: 34406372 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1557/2013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endovascular Therapy for Low NIHSS Ischemic Strokes
NCT04167527 ACTIVE_NOT_RECRUITING PHASE2/PHASE3
Minor Stroke Therapy Evaluation
NCT03796468 RECRUITING NA